中文 | English
Return
Total: 794 , 1/80
Show Home Prev Next End page: GO
Author:(FENG DA)

1.Three new gallic acid sugaresters from Elaeagnus oxycarpa Schlechtend leaves and their antioxidant and tyrosinase inhibitory activities

Feng-zhen CUI ; Jian-hong FU ; Guo-yan XU ; AYEKABAYR·EKBAYR ; Chang-da MA

Acta Pharmaceutica Sinica 2025;60(2):434-441

2.The Ferroptosis-inducing Compounds in Triple Negative Breast Cancer

Xin-Die WANG ; Da-Li FENG ; Xiang CUI ; Su ZHOU ; Peng-Fei ZHANG ; Zhi-Qiang GAO ; Li-Li ZOU ; Jun WANG

Progress in Biochemistry and Biophysics 2025;52(4):804-819

3.Outcome analysis of functional mitral regurgitation after transcatheter aortic valve replacement in patients with severe bicuspid aortic stenosis

Da-Wei LIN ; Zi-Long WENG ; Feng ZHANG ; Wen-Zhi PAN ; Da-Xin ZHOU

Fudan University Journal of Medical Sciences 2024;51(1):34-40

4.Research advances in animal models of tricuspid regurgitation

Da-Wei LIN ; Xiao-Chun ZHANG ; Feng ZHANG ; Wen-Zhi PAN ; Da-Xin ZHOU

Fudan University Journal of Medical Sciences 2024;51(2):257-261

5. Retinal microstructure and developmental characteristics in Zebrafish

Li-Ping FENG ; Jun-Yong WANG ; Jin-Xing LIN ; Yi-Lin XU ; Xun CHEN ; Xiao-Ying WANG ; Yi-Lin XU ; Xun CHEN ; Xiao-Ying WANG ; Yi-Lin XU ; Xun CHEN ; Da-Hai LIU

Acta Anatomica Sinica 2024;55(1):105-112

6.Clinical trial of indobufen combined with clopidogrel in treating elderly patients with coronary heart disease after PCI

Feng XIE ; Da-Wei LIU ; Chang-Qing YU ; Xin-Liang CHEN

The Chinese Journal of Clinical Pharmacology 2024;40(2):165-169

7.Bioequivalence study of olmesartan medoxomil tablet in Chinese healthy subjects

Na SHAN ; Da-Hai JIANG ; Lin-Lin MIAO ; Zhen-Li REN ; Peng-Bo JIN ; Pei-Qi HAO ; Li AN ; Hong ZHU ; Yong XIN ; Guang-De YANG ; Feng LIU

The Chinese Journal of Clinical Pharmacology 2024;40(20):3033-3037

8.Determination of lacidipine in Beagle dog plasma by UHPLC-MS/MS method

Yan-Yan WANG ; Yi-Hong JIANG ; Xiao-Ying ZHAO ; Zhen-Yu ZHOU ; Xiao-Hong LI ; Cheng-Da YAN ; Feng QIN

The Chinese Journal of Clinical Pharmacology 2024;40(20):3038-3041

9.Efficacy and safety of recombinant human anti-SARS-CoV-2 monoclonal antibody injection(F61 injection)in the treatment of patients with COVID-19 combined with renal damage:a randomized controlled exploratory clinical study

Ding-Hua CHEN ; Chao-Fan LI ; Yue NIU ; Li ZHANG ; Yong WANG ; Zhe FENG ; Han-Yu ZHU ; Jian-Hui ZHOU ; Zhe-Yi DONG ; Shu-Wei DUAN ; Hong WANG ; Meng-Jie HUANG ; Yuan-Da WANG ; Shuo-Yuan CONG ; Sai PAN ; Jing ZHOU ; Xue-Feng SUN ; Guang-Yan CAI ; Ping LI ; Xiang-Mei CHEN

Chinese Journal of Infection Control 2024;23(3):257-264

10.Clinical safety and validity analysis of retrograde new endo-scopic visual field in miniature pigs

Zhe KUANG ; Peng LI ; Da-Qing JIN ; Yong-Chao ZHANG ; Hui-Li GUO ; Yu-Fei ZHANG ; Guang-Lin HE ; Guo-Feng SUN ; Yuan HE

Chinese Journal of Current Advances in General Surgery 2024;27(1):14-18

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 794 , 1/80 Show Home Prev Next End page: GO